|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Münger K, Baldwin A, Edwards KM, Hayakawa
H, Nguyen CL, Owens M, Grace M and Huh K: Mechanisms of human
papillomavirus-induced oncogenesis. J Virol. 78:11451–11460. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Riley RR, Duensing S, Brake T, Münger K,
Lambert PF and Arbeit JM: Dissection of human papillomavirus E6 and
E7 function in transgenic mouse models of cervical carcinogenesis.
Cancer Res. 63:4862–4871. 2003.
|
|
6
|
McLaughlin-Drubin ME and Münger K: The
human papilloma-virus E7 oncoprotein. Virology. 384:335–344. 2009.
View Article : Google Scholar
|
|
7
|
Ghittoni R, Accardi R, Hasan U, Gheit T,
Sylla B and Tommasino M: The biological properties of E6 and E7
oncoproteins from human papillomaviruses. Virus Genes. 40:1–13.
2010. View Article : Google Scholar
|
|
8
|
Nilsson S, Mäkelä S, Treuter E, Tujague M,
Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M and
Gustafsson JA: Mechanisms of estrogen action. Physiol Rev.
81:1535–1565. 2001.
|
|
9
|
Gruber CJ, Tschugguel W, Schneeberger C
and Huber JC: Production and actions of estrogens. N Engl J Med.
346:340–352. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar
|
|
11
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
12
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17–92, is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M,
et al: Human microRNA genes are frequently located at fragile sites
and genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar
|
|
16
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar
|
|
17
|
McBee WC, Gardiner AS, Edwards RP, Lesnock
JL and Bhargava R: MicroRNA analysis in human papillomavirus
(HPV)-associated cervical neoplasia and cancer. J Carcinog Mutagen.
1:1–9. 2011.
|
|
18
|
Pereira PM, Marques JP, Soares AR, Carreto
L and Santos MAS: MicroRNA expression variability in human cervical
tissues. PLoS One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J,
Lu W, Wan X, Ma D and Xie X: Progressive miRNA expression profiles
in cervical carcinogenesis and identification of HPV-related target
genes for miR-29. J Pathol. 224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lui WO, Pourmand N, Patterson BK and Fire
A: Patterns of known and novel small RNAs in human cervical cancer.
Cancer Res. 67:6031–6043. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gómez-Gómez Y, Organista-Nava J and
Gariglio P: Deregulation of the miRNAs expression in cervical
cancer: Human papillomavirus implications. Biomed Res Int.
2013:4070522013. View Article : Google Scholar
|
|
23
|
Deftereos G, Corrie SR, Feng Q, Morihara
J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and
mir-143 in cervical specimens ranging from histologically normal
through to invasive cervical cancer. PLoS One. 6:e284232011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu L, Wang YL and Wang JF: Differential
expression of miR-21, miR-126, miR-143, miR-373 in normal cervical
tissue, cervical cancer tissue and HeLa cell. Sichuan Da Xue Xue
Bao Yi Xue Ban. 43:536–539. 2011.(In Chinese).
|
|
25
|
Yao Q, Xu H, Zhang QQ, Zhou H and Qu LH:
MicroRNA-21 promotes cell proliferation and down-regulates the
expression of programmed cell death 4 (PDCD4) in HeLa cervical
carcinoma cells. Biochem Biophys Res Commun. 388:539–542. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk
ML and Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN
and CYLD are part of the epigenetic switch linking inflammation to
cancer. Mol Cell. 39:493–506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu L, Yu X, Guo X, Tian Z, Su M, Long Y,
Huang C, Zhou F, Liu M, Wu X, et al: miR-143 is downregulated in
cervical cancer and promotes apoptosis and inhibits tumor formation
by targeting Bcl-2. Mol Med Rep. 5:753–760. 2012.
|
|
28
|
Pillai MR, Halabi S, McKalip A,
Jayaprakash PG, Rajalekshmi TN, Nair MK and Herman B: The presence
of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in
cervicovaginal smears from patients with invasive cervical cancer.
Cancer Epidemiol Biomarkers Prev. 5:329–335. 1996.PubMed/NCBI
|
|
29
|
Dimitrakakis C, Kymionis G, Diakomanolis
E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E and
Michalas S: The possible role of p53 and bcl-2 expression in
cervical carcinomas and their premalignant lesions. Gynecol Oncol.
77:129–136. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Myklebust MP, Bruland O, Fluge Ø,
Skarstein A, Balteskard L and Dahl O: MicroRNA-15b is induced with
E2F-controlled genes in HPV-related cancer. Br J Cancer.
105:1719–1725. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang S, Liu F, Mao X, Huang J, Yang J,
Yin X, Wu L, Zheng L and Wang Q: Elevation of miR-27b by HPV16 E7
inhibits PPARγ expression and promotes proliferation and invasion
in cervical carcinoma cells. Int J Oncol. 47:1759–1766.
2015.PubMed/NCBI
|
|
32
|
Bhat-Nakshatri P, Wang G, Collins NR,
Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour
EF, Liu Y, et al: Estradiol-regulated microRNAs control estradiol
response in breast cancer cells. Nucleic Acids Res. 37:4850–4861.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Herber R, Liem A, Pitot H and Lambert PF:
Squamous epithelial hyperplasia and carcinoma in mice transgenic
for the human papillomavirus type 16 E7 oncogene. J Virol.
70:1873–1881. 1996.PubMed/NCBI
|
|
34
|
Nolan T, Hands RE and Bustin SA:
Quantification of mRNA using real-time RT-PCR. Nat Protoc.
1:1559–1582. 2006. View Article : Google Scholar
|
|
35
|
Arbeit JM, Howley PM and Hanahan D:
Chronic estrogen-induced cervical and vaginal squamous
carcinogenesis in human papillomavirus type 16 transgenic mice.
Proc Natl Acad Sci USA. 93:2930–2935. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
International Collaboration of
Epidemiological Studies of Cervical Cancer. Comparison of risk
factors for invasive squamous cell carcinoma and adenocarcinoma of
the cervix: Collaborative reanalysis of individual data on 8,097
women with squamous cell carcinoma and 1,374 women with
adenocarcinoma from 12 epidemiological studies. Int J Cancer.
120:885–891. 2007. View Article : Google Scholar
|
|
37
|
Gocze K, Gombos K, Kovacs K, Juhasz K,
Gocze P and Kiss I: MicroRNA expressions in HPV-induced cervical
dysplasia and cancer. Anticancer Res. 35:523–530. 2015.
|
|
38
|
Mattie MD, Benz CC, Bowers J, Sensinger K,
Wong L, Scott GK, Fedele V, Ginzinger D, Getts R and Haqq C:
Optimized high-throughput microRNA expression profiling provides
novel biomarker assessment of clinical prostate and breast cancer
biopsies. Mol Cancer. 5:242006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao T and Lin Z: MiR-21 is involved in
cervical squamous cell tumorigenesis and regulates CCL20. Biochim
Biophys Acta. 1822:248–260. 2012. View Article : Google Scholar
|
|
40
|
Qin X, Yan L, Zhao X, Li C and Fu Y:
microRNA-21 overexpression contributes to cell proliferation by
targeting PTEN in endometrioid endometrial cancer. Oncol Lett.
4:1290–1296. 2012.PubMed/NCBI
|
|
41
|
Xu J, Zhang W, Lv Q and Zhu D:
Overexpression of miR-21 promotes the proliferation and migration
of cervical cancer cells via the inhibition of PTEN. Oncol Rep.
33:3108–3116. 2015.PubMed/NCBI
|
|
42
|
Jeong YJ, Noh EM, Lee YR, Yu HN, Jang KY,
Lee SJ, Kim J and Kim JS: 17beta-estradiol induces up-regulation of
PTEN and PPARgamma in leiomyoma cells, but not in normal cells. Int
J Oncol. 36:921–927. 2010.PubMed/NCBI
|
|
43
|
Marino M, Acconcia F and Trentalance A:
Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN
via MAP kinase in HepG2 cells. Mol Biol Cell. 14:2583–2591. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yuan H, Ito S, Senga T, Hyodo T, Kiyono T,
Kikkawa F and Hamaguchi M: Human papillomavirus type 16 oncoprotein
E7 suppresses cadherin-mediated cell adhesion via ERK and AP-1
signaling. Int J Oncol. 35:309–314. 2009.PubMed/NCBI
|
|
45
|
Miñano A, Xifró X, Pérez V,
Barneda-Zahonero B, Saura CA and Rodríguez-Alvarez J: Estradiol
facilitates neurite maintenance by a Src/Ras/ERK signalling
pathway. Mol Cell Neurosci. 39:143–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Eferl R and Wagner EF: AP-1: A
double-edged sword in tumorigenesis. Nat Rev Cancer. 3:859–868.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kakehashi A, Tago Y, Yoshida M, Sokuza Y,
Wei M, Fukushima S and Wanibuchi H: Hormonally active doses of
isoflavone aglycones promote mammary and endometrial carcinogenesis
and alter the molecular tumor environment in Donryu rats. Toxicol
Sci. 126:39–51. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fujita S, Ito T, Mizutani T, Minoguchi S,
Yamamichi N, Sakurai K and Iba H: miR-21 Gene expression triggered
by AP-1 is sustained through a double-negative feedback mechanism.
J Mol Biol. 378:492–504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Vázquez-Ulloa E, Lizano M, Avilés-Salas A,
Alfaro-Moreno E and Contreras-Paredes A: Abnormal distribution of
hDlg and PTEN in premalignant lesions and invasive cervical cancer.
Gynecol Oncol. 122:663–668. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Leslie NR and Downes CP: PTEN: The down
side of PI 3-kinase signalling. Cell Signal. 14:285–295. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bader AG, Kang S, Zhao L and Vogt PK:
Oncogenic PI3K deregulates transcription and translation. Nat Rev
Cancer. 5:921–929. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Menges CW, Baglia LA, Lapoint R and
McCance DJ: Human papillomavirus type 16 E7 up-regulates AKT
activity through the retinoblastoma protein. Cancer Res.
66:5555–5559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Guo RX, Wei LH, Tu Z, Sun PM, Wang JL,
Zhao D, Li XP and Tang JM: 17 β-estradiol activates PI3K/Akt
signaling pathway by estrogen receptor (ER)-dependent and
ER-independent mechanisms in endometrial cancer cells. J Steroid
Biochem Mol Biol. 99:9–18. 2006. View Article : Google Scholar
|
|
54
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar :
|
|
55
|
Du J, Chen GG, Vlantis AC, Chan PKS, Tsang
RKY and van Hasselt CA: Resistance to apoptosis of HPV 16-infected
laryngeal cancer cells is associated with decreased Bak and
increased Bcl-2 expression. Cancer Lett. 205:81–88. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Perillo B, Sasso A, Abbondanza C and
Palumbo G: 17β-estradiol inhibits apoptosis in MCF-7 cells,
inducing bcl-2 expression via two estrogen-responsive elements
present in the coding sequence. Mol Cell Biol. 20:2890–2901. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun
S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B
enhances hepatocarcinoma metastasis by repressing fibronectin
expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Spitkovsky D, Hehner SP, Hofmann TG,
Möller A and Schmitz ML: The human papillomavirus oncoprotein E7
attenuates NF-κB activation by targeting the Ikappa B kinase
complex. J Biol Chem. 277:25576–25582. 2002. View Article : Google Scholar : PubMed/NCBI
|
